Challenges remain for PET/CT in diagnosing lung cancer. Key among them is bolstering detection without increasing false positives. But in several studies presented at the 2005 RSNA meeting, researchers explored the quantitative data derived by the hybrid technique, and their findings could move PET/CT closer to practical use for this application.
Challenges remain for PET/CT in diagnosing lung cancer. Key among them is bolstering detection without increasing false positives. But in several studies presented at the 2005 RSNA meeting, researchers explored the quantitative data derived by the hybrid technique, and their findings could move PET/CT closer to practical use for this application.
In prior work, researchers at the University of Texas Southwestern Medical Center noted the difficulty in differentiating benign granulomas from malignant neoplasms using hybrid imaging. Benign granulomas tend to calcify and do not accumulate glucose. Malignant lesions behave the opposite way. Yet about 15% of benign lesions fail to follow this pattern, producing false positives on PET studies.
As a result, UTSMC researchers are developing new ways to visualize these lesions.
"We've spent a lot of time trying to work up a proper method for evaluating the Hounsfield unit density and the standard uptake values," said Dr. William Erdman, a professor of radiology at the university and chief of nuclear medicine at UT's Parkland Hospital in Dallas.
Erdman and colleagues retrospectively reviewed 53 patients with confirmed benign and malignant lesions. They used a 3D workstation to draw a region of interest around a suspected lesion and analyzed specific voxels within a volume showing FDG activity. After identifying air, calcium, and other elements, they measured only HU density and SUV from true tissue. They found that this technique increased PET/CT's sensitivity and specificity for characterization.
"PET/CT allows better localization and shorter imaging times," Erdman said.
A similar technique was used by Dr. Kiyoshi Nishikawa from the Miyazaki and Tsukuba universities in Japan. Nishikawa's team measured average HU density and SUV in the region of interest around pulmonary lesions from 93 patients. They found PET/CT's quantitative assessment could spot malignancies, even when these lesions were missed or misinterpreted by the PET component.
Drs. Qiang Li and Yongkang Nie from the University of Chicago developed a computer-aided detection system based on a PET/CT imaging database. The system relies on an "enhancement" filter, which highlights tumors while suppressing normal anatomic structures. The investigators achieved a high detection rate for true malignancies.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.